Hang in there, my friend.
I know it’s taken time, but look at the progress we’ve made in the past 18 months alone:
-April 2012: The FDA ordered Merck to revise the labeling on Propecia to reflect mounting evidence that it can cause persistent sexual dysfunction:
fda.gov/Drugs/DrugSafety/Inf … 299754.htm
-May 2012: PFS victim Kevin Malley stages a hunger strike on Merck’s doorstep: pfsfoundation.org/wp-content … 2-2012.jpg
-July 2012: Dr. Irwig’s research on the dangers of Propecia is picked up by the likes of Diane Sawyer, Brian Williams, Matt Lauer and Dr. Drew:
youtube.com/watch?v=uH7JgXQIV_k
-August 2012: The Post-Finasteride Syndrome Foundation is established, headed by Dr. John Santmann, an ER physician with degrees from Johns Hopkins and Washington University School of Medicine:
pfsfoundation.org/news/pfs-f … -syndrome/
-September 2012: The Australian Financial Review (aka the Wall Street Journal of Down Under) reports that “disaffected consumers in the United States and Canada…have established the Post Finasteride Syndrome Foundation with the primary goal of finding a cure and a secondary goal of raising awareness of the syndrome”:
afr.com/p/lifestyle/mens_hea … hspW7YRwBJ
…and, in turn, Wikipedia editors cite the PFS Foundation on Merck’s Wikipedia page, under the “Propecia” section:
en.wikipedia.org/wiki/Merck_%26_Co.#cite_note-49
-March 2013: The PFS Foundation is granted nonprofit status by the IRS as a public charity:
pfsfoundation.org/news/the-p … c-charity/
-July 2013: Harvard Medical School teaching affiliate Brigham and Women’s Hospital launches a PFS Foundation-funded clinical study of PFS, aiming to “identify causes at molecular level of this condition potentially affecting thousands of men worldwide”:
pfsfoundation.org/news/clini … affiliate/
And that, I promise you, is just the beginning.
The walls are fast closing in on Merck CEO Kenneth C. Frazier. He knows it. All he can do now is try and limit the company’s liability to a few billion dollars. If, as with Vioxx, he can get out of this one for under $10 billion, the financial community will once again hail him as a hero.
So be it.
But at least a good chunk of those billions will be poured into additional medical research that, hopefully, leads to effective treatments in the coming years.
At that point, it will be comforting to know that Merck can never again utter the words “There is no scientific data showing that [Propecia and Proscar] cause persistent impotence after discontinuing use,” as Merck spokeswoman Lainie Keller told The Toronto Star in April:
thestar.com/news/canada/2013 … otent.html